Although the results of our study provide the first evidence that SNPs in the CUBN, HNF1A, and LIPC genes could be prognostic biomarkers useful for CAD prevention, a prospective study involving a larger cohort of patients and functional studies are required to validate these findings. The gene discussed is HNF1A; the disease is coronary artery disorder.